Munich Personal RePEc Archive

Factors affecting productivity of research-based pharmaceutical companies following mergers and acquisitions

Tjandrawinata, Raymond R. and Simanjuntak, Destrina Grace (2012): Factors affecting productivity of research-based pharmaceutical companies following mergers and acquisitions.

[img]
Preview
PDF
MPRA_paper_42514.pdf

Download (329Kb) | Preview

Abstract

This paper analyzes the impact of mergers and acquisitions (M&A) activities in research-based pharmaceutical companies, specifically the impact of R&D expenditure, profitability, and sales revenue on firms’ productivity, R&D intensity, in pharmaceutical industries following M&A activities. The model was estimated using annual data, gathered from seven large research-based pharmaceutical companies pre and post-M&A, during the period 2003 until 2010. The regression analysis method uses a fixed effect method with generalized least square (GLS) analysis. The result further shows that following M&A activities, firms’ one-year lagged R&D expenditure (t-1) and lagged profitability (t-1) to be positive in increasing significantly the firms’ amount of R&D intensity in research-based pharmaceutical industries, while, surprisingly firms’ one-year lagged sales revenue (t-1) have a negative impact in increasing significantly the firms’ amount of R&D intensity in research-based pharmaceutical industries.

UB_LMU-Logo
MPRA is a RePEc service hosted by
the Munich University Library in Germany.